These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25506914)

  • 21. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials.
    Alfano LN; Miller NF; Berry KM; Yin H; Rolf KE; Flanigan KM; Mendell JR; Lowes LP
    Neuromuscul Disord; 2017 May; 27(5):452-457. PubMed ID: 28279570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal Evaluation of Muscle Composition Using Magnetic Resonance in 4 Boys With Duchenne Muscular Dystrophy: Case Series.
    Senesac CR; Lott DJ; Forbes SC; Mathur S; Arpan I; Senesac ES; Walter GA; Vandenborne K
    Phys Ther; 2015 Jul; 95(7):978-88. PubMed ID: 25592189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study.
    Mazzone E; Vasco G; Sormani MP; Torrente Y; Berardinelli A; Messina S; D'Amico A; Doglio L; Politano L; Cavallaro F; Frosini S; Bello L; Bonfiglio S; Zucchini E; De Sanctis R; Scutifero M; Bianco F; Rossi F; Motta MC; Sacco A; Donati MA; Mongini T; Pini A; Battini R; Pegoraro E; Pane M; Gasperini S; Previtali S; Napolitano S; Martinelli D; Bruno C; Vita G; Comi G; Bertini E; Mercuri E
    Neurology; 2011 Jul; 77(3):250-6. PubMed ID: 21734183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative electromyography in ambulatory boys with Duchenne muscular dystrophy.
    Verma S; Lin J; Travers C; McCracken C; Shah D
    Muscle Nerve; 2017 Dec; 56(6):1168-1171. PubMed ID: 28457006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of type 2 diabetes on energy cost and preferred speed of walking.
    Caron N; Peyrot N; Caderby T; Verkindt C; Dalleau G
    Eur J Appl Physiol; 2018 Nov; 118(11):2331-2338. PubMed ID: 30088134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of ambulatory capacity and disease progression of Duchenne muscular dystrophy subjects enrolled in the drisapersen DMD114673 study with a matched natural history cohort of subjects on daily corticosteroids.
    Goemans N; Tulinius M; Kroksmark AK; Wilson R; van den Hauwe M; Campion G
    Neuromuscul Disord; 2017 Mar; 27(3):203-213. PubMed ID: 28169120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hip kinetics during gait are clinically meaningful outcomes in young boys with Duchenne muscular dystrophy.
    Heberer K; Fowler E; Staudt L; Sienko S; Buckon CE; Bagley A; Sison-Williamson M; McDonald CM; Sussman MD
    Gait Posture; 2016 Jul; 48():159-164. PubMed ID: 27267770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accuracy of Parent-Reported Energy Intake and Physical Activity Levels in Boys With Duchenne Muscular Dystrophy.
    Elliott SA; Davidson ZE; Davies PS; Truby H
    Nutr Clin Pract; 2015 Apr; 30(2):297-304. PubMed ID: 25200647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early Gross Motor Milestones in Duchenne Muscular Dystrophy.
    Norcia G; Lucibello S; Coratti G; Onesimo R; Pede E; Ferrantini G; Brogna C; Cicala G; Carnicella S; Forcina N; Fanelli L; Pane M; Mercuri E
    J Neuromuscul Dis; 2021; 8(4):453-456. PubMed ID: 33935100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Walking activity in a large cohort of boys with Duchenne muscular dystrophy.
    Lott DJ; Taivassalo T; Senesac CR; Willcocks RJ; Harrington AM; Zilke K; Cunkle H; Powers C; Finanger EL; Rooney WD; Tennekoon GI; Vandenborne K
    Muscle Nerve; 2021 Feb; 63(2):192-198. PubMed ID: 33188573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of AFO use on walking in boys with Duchenne muscular dystrophy: a pilot study.
    Townsend EL; Tamhane H; Gross KD
    Pediatr Phys Ther; 2015; 27(1):24-9. PubMed ID: 25401456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of functional benefit with glutamine versus placebo in Duchenne muscular dystrophy: a randomized crossover trial.
    Mok E; Letellier G; Cuisset JM; Denjean A; Gottrand F; Alberti C; Hankard R
    PLoS One; 2009; 4(5):e5448. PubMed ID: 19421321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Body composition and energy expenditure in Duchenne muscular dystrophy.
    Zanardi MC; Tagliabue A; Orcesi S; Berardinelli A; Uggetti C; Pichiecchio A
    Eur J Clin Nutr; 2003 Feb; 57(2):273-8. PubMed ID: 12571659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data.
    Pane M; Coratti G; Brogna C; Mazzone ES; Mayhew A; Fanelli L; Messina S; D'Amico A; Catteruccia M; Scutifero M; Frosini S; Lanzillotta V; Colia G; Cavallaro F; Rolle E; De Sanctis R; Forcina N; Petillo R; Barp A; Gardani A; Pini A; Monaco G; D'Angelo MG; Zanin R; Vita GL; Bruno C; Mongini T; Ricci F; Pegoraro E; Bello L; Berardinelli A; Battini R; Sansone V; Albamonte E; Baranello G; Bertini E; Politano L; Sormani MP; Mercuri E
    PLoS One; 2018; 13(6):e0199223. PubMed ID: 29924848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study.
    Goemans NM; Tulinius M; van den Hauwe M; Kroksmark AK; Buyse G; Wilson RJ; van Deutekom JC; de Kimpe SJ; Lourbakos A; Campion G
    PLoS One; 2016; 11(9):e0161955. PubMed ID: 27588424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suitability of North Star Ambulatory Assessment in young boys with Duchenne muscular dystrophy.
    De Sanctis R; Pane M; Sivo S; Ricotti V; Baranello G; Frosini S; Mazzone E; Bianco F; Fanelli L; Main M; Corlatti A; D'Amico A; Colia G; Scalise R; Palermo C; Alfonsi C; Tritto G; Romeo DM; Graziano A; Battini R; Morandi L; Bertini E; Muntoni F; Mercuri E
    Neuromuscul Disord; 2015 Jan; 25(1):14-8. PubMed ID: 25454732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Individualized Prediction of Changes in 6-Minute Walk Distance for Patients with Duchenne Muscular Dystrophy.
    Goemans N; Vanden Hauwe M; Signorovitch J; Swallow E; Song J;
    PLoS One; 2016; 11(10):e0164684. PubMed ID: 27737016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lightweight, modular knee-ankle-foot orthosis for Duchenne muscular dystrophy: design, development, and evaluation.
    Taktak DM; Bowker P
    Arch Phys Med Rehabil; 1995 Dec; 76(12):1156-62. PubMed ID: 8540794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prednisolone therapy in Duchenne muscular dystrophy prolongs ambulation and prevents scoliosis.
    Yilmaz O; Karaduman A; Topaloğlu H
    Eur J Neurol; 2004 Aug; 11(8):541-4. PubMed ID: 15272899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth, bone health & ambulatory status of boys with DMD treated with daily vs. intermittent oral glucocorticoid regimen.
    Crabtree NJ; Adams JE; Padidela R; Shaw NJ; Högler W; Roper H; Hughes I; Daniel A; Mughal MZ
    Bone; 2018 Nov; 116():181-186. PubMed ID: 30055340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.